These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17493863)

  • 1. How TNF was recognized as a key mechanism of disease.
    Clark IA
    Cytokine Growth Factor Rev; 2007; 18(3-4):335-43. PubMed ID: 17493863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LILRA5 is expressed by synovial tissue macrophages in rheumatoid arthritis, selectively induces pro-inflammatory cytokines and IL-10 and is regulated by TNF-alpha, IL-10 and IFN-gamma.
    Mitchell A; Rentero C; Endoh Y; Hsu K; Gaus K; Geczy C; McNeil HP; Borges L; Tedla N
    Eur J Immunol; 2008 Dec; 38(12):3459-73. PubMed ID: 19009525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of tumor necrosis factor in health and disease.
    Beutler BA
    J Rheumatol Suppl; 1999 May; 57():16-21. PubMed ID: 10328138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myelodysplasia and anemia of chronic disease in human tumor necrosis factor-alpha transgenic mice.
    Capocasale RJ; Makropoulos DA; Achuthanandam R; Stowell N; Quinn J; Rafferty PA; O'Brien J; Emmell E; Bugelski PJ
    Cytometry A; 2008 Feb; 73(2):148-59. PubMed ID: 18205195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNF-mediated inflammatory disease.
    Bradley JR
    J Pathol; 2008 Jan; 214(2):149-60. PubMed ID: 18161752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low level light effects on inflammatory cytokine production by rheumatoid arthritis synoviocytes.
    Yamaura M; Yao M; Yaroslavsky I; Cohen R; Smotrich M; Kochevar IE
    Lasers Surg Med; 2009 Apr; 41(4):282-90. PubMed ID: 19347944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of Gd@C82(OH)22 nanoparticles on the release of Th1/Th2 cytokines and induction of TNF-alpha mediated cellular immunity.
    Liu Y; Jiao F; Qiu Y; Li W; Lao F; Zhou G; Sun B; Xing G; Dong J; Zhao Y; Chai Z; Chen C
    Biomaterials; 2009 Aug; 30(23-24):3934-45. PubMed ID: 19403166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Along a TNF-paved road from dead parasites in red cells to cerebral malaria, and beyond.
    Clark IA
    Parasitology; 2009 Oct; 136(12):1457-68. PubMed ID: 19450376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural regulatory (CD4+CD25+FOXP+) T cells control the production of pro-inflammatory cytokines during Plasmodium chabaudi adami infection and do not contribute to immune evasion.
    Cambos M; Bélanger B; Jacques A; Roulet A; Scorza T
    Int J Parasitol; 2008 Feb; 38(2):229-38. PubMed ID: 17868677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rheumatoid arthritis and interleukin-32.
    Shoda H; Fujio K; Yamamoto K
    Cell Mol Life Sci; 2007 Oct; 64(19-20):2671-9. PubMed ID: 17619821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of TNF receptor 1 reduces disease severity but increases parasite transmission during Plasmodium chabaudi chabaudi infection.
    Long GH; Chan BH; Allen JE; Read AF; Graham AL
    Int J Parasitol; 2008 Jul; 38(8-9):1073-81. PubMed ID: 18226816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of tumor necrosis factor-alpha in acute pancreatitis: from biological basis to clinical evidence.
    Malleo G; Mazzon E; Siriwardena AK; Cuzzocrea S
    Shock; 2007 Aug; 28(2):130-40. PubMed ID: 17529903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNF signaling: early events and phosphorylation.
    Ihnatko R; Kubes M
    Gen Physiol Biophys; 2007 Sep; 26(3):159-67. PubMed ID: 18063842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor as a pharmacological target.
    Ghezzi P; Cerami A
    Methods Mol Med; 2004; 98():1-8. PubMed ID: 15064428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated macrophage-like THP-1 cells modulate anulus fibrosus cell production of inflammatory mediators in response to cytokines.
    Kim JH; Studer RK; Sowa GA; Vo NV; Kang JD
    Spine (Phila Pa 1976); 2008 Oct; 33(21):2253-9. PubMed ID: 18784630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour necrosis factor: implications for surgical patients.
    Khalil AA; Hall JC; Aziz FA; Price P
    ANZ J Surg; 2006 Nov; 76(11):1010-6. PubMed ID: 17054552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intervention of an inflammation amplifier, triggering receptor expressed on myeloid cells 1, for treatment of autoimmune arthritis.
    Murakami Y; Akahoshi T; Aoki N; Toyomoto M; Miyasaka N; Kohsaka H
    Arthritis Rheum; 2009 Jun; 60(6):1615-23. PubMed ID: 19479878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivation of tuberculosis by tumor necrosis factor neutralization.
    Jacobs M; Samarina A; Grivennikov S; Botha T; Allie N; Fremond C; Togbe D; Vasseur V; Rose S; Erard F; Monteiro A; Quesniaux V; Ryffel B
    Eur Cytokine Netw; 2007 Mar; 18(1):5-13. PubMed ID: 17400533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential target of infliximab in autoimmune and inflammatory diseases.
    Atzeni F; Doria A; Carrabba M; Turiel M; Sarzi-Puttini P
    Autoimmun Rev; 2007 Sep; 6(8):529-36. PubMed ID: 17854744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of TNF in malaria and other parasitic infections.
    Clark IA; Cowden WB
    Immunol Ser; 1992; 56():365-407. PubMed ID: 1550869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.